This video gives you the fastest and easiest method to understand and sketch parabolas—no complex math required. We break it down step-by-step: finding the vertex, identifying the axis of symmetry, ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Google featured an animated quadratic equation doodle on its homepage in India on Nov 12 The quadratic formula models parabolic paths like basketball shots in physics and engineering Clicking the ...

Vertex Pharmaceuticals (VRTX) reported $3.08 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 11%. EPS of $4.80 for the same period compares to $4.38 ...

The story so far: If you think of a cyclone as a machine, it would be an incredibly powerful entity — an engine that draws heat from the earth’s tropical waters to drive destructive winds, heavy and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA nephropathy, along with key clinical advancements in its kidney disease ...

Even amid political pressure from RFK Jr. and President Trump, as well as failed clinical data on VX-993, Vertex continues to strengthen its position in the cystic fibrosis market. Sales of its three ...

Vertex Pharmaceuticals Incorporated is downgraded from Buy to Hold due to mounting headwinds and pipeline uncertainties. Vertex faces pressure from potential U.S. drug pricing reforms and tariffs, ...